Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time

Transfusion

Volumn 38, Issue 3, 1998, Pages 271-278

  Larsson, S ^a,b   Soderberg Naucler C ^c   Wang, F Z ^a,d   Moller E ^a,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Biosciences at Novum   (Sweden)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e Department of Biosciences at Novum

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD DONOR; CYTOMEGALOVIRUS INFECTION; HUMAN; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION;

EID: 2642678466     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38398222871.x     Document Type: Article

References (36)

1. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990;12(Suppl 7): S701-10.
2. Kääriäinen L, Klemola E, Paloheimo J. Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J 1966:5498:1270-2.
3. Lang DJ, Scolnick EM, Willerson JT. Association of cytomegalovirus infection with the postperfusion syndrome. N Engl J Med 1968;278:1147-9.
4. Prince AM, Szmuness W, Millian SJ, David DS. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med 1971:284:1125-31.
5. Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983;5:977-93.
6. Tegtmeier GE. Posttransfusion cytomegalovirus infections. Arch Pathol Lab Med 1989;113:236-45.
7. Gunter KC. Transfusion-transmitted cytomegalovirus: the part-time pathogen. Pediatr Pathol Lab Med 1995;15:515-34.
8. Ibanez CE, Schrier R, Ghazal P, et al. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991:65:6581-8.
9. Schrier RD, Nelson JA, Oldstone MB. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985;230:1048-51.
10. Bowden RA. Transfusion-transmitted cytomegalovirus infection. Hematol Oncol Clin North Am 1995;9:155-66.
11. Söderberg C, Larsson S, Bergstedt-Lindqvist S, Möller E. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 1993;67:3166-75.
12. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72:2059-64.
13. Dankner WM, McCutchan JA, Richman DD, et al. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 1990;161:31-6.
14. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev Infect Dis 1983;5:205-15.
15. Hersman J, Meyers JD, Thomas ED, et al. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982;96:149-52.
16. Winston DJ, Ho WG, Bartoni K, Champlin RE. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients. Bone Marrow Transplant 1993;12:283-8.
17. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
18. Söderberg-Nauclér C, Fish K, Nelson J. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-26.
19. Winston DJ, Ho WG, Howell CL, et al. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980;93:671-5.
20. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153:478-88.
21. Cassol SA, Poon MC, Pal R, et al. Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients. J Clin Invest 1989;83:1109-15.
22. Miller WJ, McCullough J, Balfour H Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991;7:227-34.
23. Chou S, Kim DY, Norman DJ. Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates. J Infect Dis 1987;155:565-7.
24. Bevan IS, Daw RA, Day PJ, et al. Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population. Br J Haematol 1991;78:94-9.
25. Stanier P, Taylor DL, Kitchen AD, et al. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 1989;299:897-8.
26. Smith KL, Kulski JK, Cobain T, Dunstan RA. Detection of cytomegalovirus in blood donors by the polymerase chain reaction. Transfusion 1993;33:497-503.
27. Zhang LJ, Hanff P, Rutherford C, et al. Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis 1995;171:1002-6.
28. Sundqvist VA, Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods 1981;2:301-12.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
30. Akrigg A, Wilkinson GW, Oram JD. The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res 1985;2:107-21.
31. Jahn G, Kouzarides T, Mach M, et al. Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J Virol 1987;61:1358-67.
32. Chen EY, Cheng A, Lee A, et al. Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome. Genomics 1991;10:792-800.
33. Ahlfors K. IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand J Infect Dis 1984;16:335-7.
34. Struve J, Aronsson B, Frenning B, et al. Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinanct hepatitis B vaccine. Scand J Infect Dis 1994;26:468-70.
35. Söderberg C, Sumitran-Karuppan S, Ljungman P, Möller E. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation 1996;61:594-600.
36. Söderberg C, Larsson S, Rozell B,et al. Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. Transplantation 1996:61:600-609.